Efficacy of Ayurvedic Management in Diabetes Mellitus Type II – A Case Study

Diabetes mellitus is a metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both. The chronic hyperglycemia of diabetes is associated with long-term damage, dysfunction, and failure of various organs, and can cause Diabetic Retinopathy, Chronic Kidney Disease, Diabetic Neuropathy, and cardiovascular disorder. Out of 20 types of Prameha, Madhumeha is one type of Vataj Prameha which greatly resembling diabetes mellitus type 2. Additionally, Madhumeha also corrupts Oja (immunity). A 56-year-old Male, known case of Diabetes Mellitus Type 2 visited Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, India, with complaints of uncontrolled Blood Glucose level with raised HbA1c level along with Vibandh (Constipation), Bahumutrata (Polyuria), Bala Kshaya (General weakness), Ajeerna (Indigestion), and Tanava (Stress). He was on Vildagliptin 50 mg with Metformin 500 mg once daily for 6 months. The symptoms and lab parameters however did not improved significantly. He was advised indoor treatment at Jeena Sikho Lifecare Limited Hospital, Derabassi, Punjab, India for Ayurvedic management for 9 days. Treatment protocol included Nidan Parivarjan (avoiding the causative factors), Dietary and lifestyle modifications, Shodhan Chikitsa by Panchkarma (removal of toxin from the body) and Shaman Chikitsa (controlling of aggravating Doshas in the body) by Ayurvedic Medicines consisting of ingredients like Triphala (Emblica officinalis, Terminalia bellirica, Terminalia chebula), Shilajit (Black Bitumen), Ashwagandha (Withania somnifera), Guduchi (Tinospora cordifolia), Neem (Azadirachta indica), Karela (Momordica charantia) etc. The patient followed all the treatments carefully, agreed to taper down the Allopathic tablets completely stopping in four days and kept on showing significant improvements in symptoms and lab parameters. Following the inpatient treatment, the doctor and patient remained in regular contact with proper follow-ups until May 31st, 2025. During this time, the patient consistently shared his blood glucose readings and HbA1c levels, which showed continuous improvement. This case study paves path for successful implementation of Ayurvedic regimen against DMT2, however for a disease as common as DM T2 a larger sample size will be more appropriate.